SCHEMBL6898666

SCHEMBL6898666

N=C(N)NCCC[C@H](C(N)=O)N(Cc1ccc(CNC(N)=O)cc1)C(=O)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
NPY1R P25929 4/20 0.36
NPY5R Q15761 2/20 0.35
NPY2R P49146 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CNR1 P21554 2/20 0.35
CNR2 P34972 1/20 0.35
NPY4R P50391 2/20 0.33
THRB P10828 1/20 0.33
LSS P48449 1/20 0.33
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
UTS2R Q9UKP6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7040089 0.94 CYP2C9 (0.40) CYP2C9CYP2C19NPY1RNPY5RNPY2R
SCHEMBL6898240 0.91 NPY1R (0.38) NPY1RNPY5RNPY2RNPY4R
SCHEMBL8059173 0.91 CYP2C9 (0.44) CYP2C9CYP2C19NPY1RNPY5RNPY2R
SCHEMBL6898966 0.91 TDP1 (0.36) CYP2C9CYP2C19NPY1RNPY5RKMT2A
SCHEMBL7059809 0.90 NPY1R (0.42) NPY1RNPY5RKMT2AMEN1CNR1
SCHEMBL6899868 0.90 NPY1R (0.42) NPY1RNPY5RKMT2AMEN1CNR1
SCHEMBL4651999 0.89 CNR1 (0.43) NPY1RNPY5RNPY2RKMT2AMEN1
Hydrochloric Acid SCHEMBL8120200 0.89 CNR1 (0.43) NPY1RNPY5RNPY2RKMT2AMEN1
SCHEMBL6900020 0.88 CASR (0.38) KMT2AMEN1RAB9ASMN1; SMN2CNR1
SCHEMBL7595138 0.86 CYP2C9 (0.44) CYP2C9CYP2C19NPY1RNPY5RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885186-B1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM THOMAE GMBH DR K (DE) 2003-03-26 EP claimed
US-20040029953-A1 Use of neuropeptide-y antagonists in treatment of alcoholism THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-02-12 US disclosed
EP-0885186-B1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM THOMAE GMBH DR K (DE) 2003-03-26 EP disclosed
EP-0885186-A1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM Dr. Karl Thomae GmbH (DE) 1998-12-23 EP disclosed
WO-1997019911-A1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM DR. KARL THOMAE GMBH (DE) 1997-06-05 WO disclosed